Omeros Corporation (OMER)

06:54 AM

Omeros Achieves Profitability as Strategic Moves Slash Debt - AD HOC NEWS

06:54 AM

06:59 AM

Breakout Zone: Is Omeros Corporation impacted by rising rates2026 Summary & Safe Entry Point Identification - baoquankhu1.vn

06:59 AM

Apr 04, 2026

Omeros (NASDAQ:OMER) Upgraded by Wall Street Zen to Hold Rating - marketbeat.com

Apr 04, 2026

Apr 03, 2026

Omeros Turns Corner With Novo Deal, YARTEMLEA Launch - TipRanks

Apr 03, 2026

Apr 03, 2026

Omeros Q4 2025 earnings preview - MSN

Apr 03, 2026

Apr 03, 2026

HC Wainwright Brokers Increase Earnings Estimates for Omeros - marketbeat.com

Apr 03, 2026

Apr 03, 2026

Omeros rises as Novo deal boosts Q4 earnings - MSN

Apr 03, 2026

Apr 02, 2026

Travel Stocks: Can Omeros Corporation withstand a market correctionMarket Volume Report & AI Powered Trade Plan Recommendations - baoquankhu1.vn

Apr 02, 2026

Apr 02, 2026

Omeros (NASDAQ:OMER) Shares Down 6.5%Here's Why - MarketBeat

Apr 02, 2026

Apr 02, 2026

Omeros: Making The Bull Case On Q4 Earnings, Ahead Of Key Q1 Commercial Updates (OMER) - Seeking Alpha

Apr 02, 2026

Apr 02, 2026

Omeros Corporation (NASDAQ:OMER) Q4 2025 Earnings Call Transcript - Insider Monkey

Apr 02, 2026

Apr 02, 2026

OMER Stock Surges 5% After Hours On Novo Nordisk Deal Windfall And Drug Launch Optimism - Stocktwits

Apr 02, 2026

Apr 01, 2026

Omeros Shares Surge on Stellar Earnings and Strategic Progress - AD HOC NEWS

Apr 01, 2026

Apr 01, 2026

Omeros stock rises after Q4 earnings beat (OMER:NASDAQ) - Seeking Alpha

Apr 01, 2026

Apr 01, 2026

Omeros Sees Unusually Large Options Volume (NASDAQ:OMER) - marketbeat.com

Apr 01, 2026

Apr 01, 2026

Omeros (NASDAQ:OMER) Shares Gap UpShould You Buy? - marketbeat.com

Apr 01, 2026

Apr 01, 2026

Omeros Corporation Q4 2025 Earnings Call Summary - Yahoo Finance

Apr 01, 2026

Apr 01, 2026

Omeros expects YARTEMLEA to be financially self-sustaining in 2026 and targets positive cash flow in 2027 - msn.com

Apr 01, 2026

Apr 01, 2026

Omeros reports Q4 EPS $1.22, consensus 36c - TipRanks

Apr 01, 2026

Apr 01, 2026

Transcript : Omeros Corporation, Q4 2025 Earnings Call, Mar 31, 2026 - MarketScreener

Apr 01, 2026

Mar 31, 2026

Omeros Corp (OMER) Q4 2025 Earnings Call Highlights: A Turnaroun - GuruFocus

Mar 31, 2026

Mar 31, 2026

Omeros (NASDAQ:OMER) Releases Earnings Results, Beats Estimates By $3.69 EPS - marketbeat.com

Mar 31, 2026

Mar 31, 2026

OMER stock surges 5% after hours on Novo Nordisk deal windfall and drug launch optimism - MSN

Mar 31, 2026

Mar 31, 2026

Omeros Corp reports results for the quarter ended September 30Earnings Summary - TradingView

Mar 31, 2026

Mar 31, 2026

Omeros Corporation Reports Q4 and Full-Year 2025 Results - National Today

Mar 31, 2026

Mar 31, 2026

Omeros Q4 Earnings Call Highlights - marketbeat.com

Mar 31, 2026

Mar 31, 2026

Earnings call transcript: Omeros Corporation Q4 2025 sees remarkable earnings beat By Investing.com - Investing.com South Africa

Mar 31, 2026

Mar 31, 2026

Earnings call transcript: Omeros Corporation Q4 2025 sees remarkable earnings beat - Investing.com

Mar 31, 2026

Mar 31, 2026

Omeros (OMER) Posts Strong Q4 Results Amid Strategic Advances - GuruFocus

Mar 31, 2026

Mar 31, 2026

OMEROS ($OMER) Releases Q4 2025 Earnings, Stock Rises - Quiver Quantitative

Mar 31, 2026

Mar 31, 2026

Omeros: Q4 Earnings Snapshot - MarketScreener

Mar 31, 2026

Mar 31, 2026

Omeros (NASDAQ: OMER) wins TA‑TMA approval and $240M Novo Nordisk pact - Stock Titan

Mar 31, 2026

Mar 31, 2026

Omeros Corporation Reports Earnings Results for the Fourth Quarter Ended December 31, 2025 - MarketScreener

Mar 31, 2026

Mar 31, 2026

Omeros Corporation Reports Fourth Quarter and Year-End 2025 Financial Results - The Joplin Globe

Mar 31, 2026

Mar 31, 2026

BRIEF-Omeros Corporation Q4 EPS USD 1.22 - TradingView

Mar 31, 2026

Mar 31, 2026

After $240M Novo deal, Omeros launches first approved TA-TMA drug - Stock Titan

Mar 31, 2026

Mar 31, 2026

Omeros Corporation's Cash Flow Timelines and Formulary Approval Claims Clash in 2025 Earnings Call - bitget.com

Mar 31, 2026

Mar 31, 2026

Omeros Q4 2025 Earnings Call Transcript - MarketBeat

Mar 31, 2026

Mar 31, 2026

Omeros (NASDAQ:OMER) Share Price Passes Above 200 Day Moving AverageHere's Why - marketbeat.com

Mar 31, 2026

Mar 27, 2026

Aug Sectors: Is Omeros Corporation a play on infrastructure spendingFed Meeting & Reliable Volume Spike Alerts - baoquankhu1.vn

Mar 27, 2026

Mar 27, 2026

Vanguard entities disaggregate OMER holdings (OMER) after internal realignment - Stock Titan

Mar 27, 2026

Mar 27, 2026

OMER Forecast, Price Target & Analyst Ratings | OMEROS CORP (NASDAQ:OMER) - chartmill.com

Mar 27, 2026

Mar 27, 2026

Omeros Corporation to Announce Fourth Quarter and Full-Year 2025 Financial Results on March 31, 2026 - BioSpace

Mar 27, 2026

Mar 27, 2026

Omeros Corp Stock: Biotech Innovator Focused on Complement Inhibitors Ahead of Q4 2025 Earnings - AD HOC NEWS

Mar 27, 2026

Mar 26, 2026

Omeros Corporation (OMER.US) is scheduled to release its earnings report after the market closes on March 31. - 富途牛牛

Mar 26, 2026

Mar 26, 2026

Sentiment Recap: Can Omeros Corporation withstand a market correctionQuarterly Profit Review & Free Reliable Trade Execution Plans - baoquankhu1.vn

Mar 26, 2026

Mar 23, 2026

Omeros (OMER) Projected to Post Earnings on Monday - marketbeat.com

Mar 23, 2026

Mar 21, 2026

Omeros Announces Upcoming Presentation at EBMT 2026 Highlighting Advances in TA-TMA Treatment - PharmiWeb.com

Mar 21, 2026

Mar 19, 2026

GeekWire Awards: Billion-dollar deals, rare IPO, pharma pact, and mega-round vie for Deal of the Year - GeekWire

Mar 19, 2026

Mar 18, 2026

Omeros Corporation (NASDAQ:OMER) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat

Mar 18, 2026

Mar 17, 2026

OMER SEC FilingsOmeros 10-K, 10-Q, 8-K Forms - Stock Titan

Mar 17, 2026